Skip to content
Directory

Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
54
currently held
Exits tracked
51
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital
Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital
Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital
Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin
Lauxera Capital Partners1 month ago

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin
Ardian1 month ago

Chairman update · Chairman update: du conseil de surveillance Thomas, Patrick · Chairman information updated

admin
PharmaFrance
75 companies matching · Page 1 of 2
Ceva
Ceva
MED Rise
France
Active
Sector
Pharma
InvestorARCHIMED
Entry
1999
Hold
16yr
Owners
16
Olyos
Olyos
LFPI Capital
France
Active
Sector
Pharma
InvestorLFPI GESTION
Entry
2018
Hold
7yr
Owners
3
Ceva Sante Animale
Ceva Sante Animale
MED II
France
Active
Sector
Pharma
InvestorARCHIMED
Entry
2025
Hold
1yr
Owners
2
ProductLife Group
ProductLife Group
Oakley Capital Fund V
France
Active
Sector
Pharma
InvestorOakley Capital
Entry
2017
Hold
7yr
Owners
3
Biovian
Biovian
ERES III
France
Active
Sector
Pharma
InvestorElyan Partners
Entry
2018
Hold
8yr
Owners
2
Biose Industrie
Biose Industrie
Cathay Capital Small Cap III
France
Exited
Sector
Pharma
InvestorCathay Capital
Entry
2020
Hold
4yr
Exit
2024
to L-GAM / BPI France (French Tech Souveraineté)
Synerlab
Crédit Mutuel Equity
France
Active
Sector
Pharma
InvestorCrédit Mutuel Equity
Entry
2007
Hold
11yr
Owners
4
GTP Bioways
Mérieux Participations 3
France
Exited
Sector
Pharma
InvestorMerieux Equity Partners
Entry
2019
Hold
5yr
Exit
2024
to Olon Group
Unither
Unither
IK Partnership Fund II
France
Active
Sector
Pharma
InvestorIK Partners
Entry
1993
Hold
33yr
Owners
6
Cenexi
Cenexi
Indigo Capital I
France
Active
Sector
Pharma
InvestorIndigo Capital
Entry
2008
Hold
9yr
Owners
3
Laboratoires Delbert
Vivalto Partners Fund I
France
Active
Sector
Pharma
InvestorVivalto Partners
Entry
2022
Hold
4yr
Owners
5
CordenPharma
CordenPharma
Astorg Mid-Cap
France
Active
Sector
Pharma
InvestorAstorg
Entry
2006
Hold
16yr
Owners
2
Doc Generici
ICG Europe Mid-Market Fund I
France
Active
Sector
Pharma
InvestorICG
Entry
2013
Hold
7yr
Owners
4
Minafin
Minafin
QCP Buyout Fund III
France
Active
Sector
Pharma
InvestorQuilvest Capital Partners
Entry
2011
Hold
9yr
Owners
6
Audevard
Audevard
Ekkio Capital IV
France
Exited
Sector
Pharma
InvestorEkkio Capital
Entry
2015
Hold
6yr
Exit
2021
to LIM Group
HRA Pharma
HRA Pharma
Astorg VI
France
Exited
Sector
Pharma
InvestorAstorg
Entry
2016
Hold
5yr
Exit
2021
to Perrigo Company
OHRE Pharma
Vatel Capital
France
Exited
Sector
Pharma
InvestorVATEL CAPITAL
Entry
2018
Hold
3yr
Exit
2021
to Strategic Generics France
Axpharma
Axpharma
FPCI Galiena III
France
Exited
Sector
Pharma
InvestorGaliena Capital
Entry
2015
Hold
5yr
Exit
2020
to ProductLife Group (backed by 21 Invest)
CYCLOPHARMA
SGCP Evergreen (balance sheet)
France
Exited
Sector
Pharma
InvestorSociete Generale Capital Partenaires
Entry
2007
Hold
11yr
Exit
2018
to Curium
Unither Pharmaceuticals
Unither Pharmaceuticals
IK Partnership Fund II
France
Active
Sector
Pharma
InvestorIK Partners
Entry
2011
Hold
9yr
Owners
4
EA PHARMA (GROUPE)
EA PHARMA (GROUPE)
Naxicap Legacy Funds
France
Exited
Sector
Pharma
InvestorNaxicap Partners
Entry
2006
Hold
11yr
Exit
2017
Actelion
Wellington Partners Life Sciences
France
Exited
Sector
Pharma
InvestorWellington Partners
Entry
1998
Hold
19yr
Owners
2
Exit
2017
to Johnson & Johnson
ALIZÉ PHARMA SAS
Capital Santé 2
France
Exited
Sector
Pharma
InvestorTurenne Groupe
Entry
2014
Hold
3yr
Exit
2017
to Millendo Therapeutics
Isochem
AURELIUS Opportunities V
France
Exited
Sector
Pharma
InvestorAURELIUS
Entry
2010
Hold
7yr
Exit
2017
to PMC Group
Tridem Pharma
Paluel-Marmont Capital Fund
France
Exited
Sector
Pharma
InvestorPaluel-Marmont Capital
Entry
2011
Hold
6yr
Exit
2017
to Fosun Pharma
Seqens
Seqens
CM-CIC Debt Fund 3
France
Active
Sector
Pharma
InvestorCIC Private Debt
Entry
2011
Hold
10yr
Owners
6
PHYSICA PHARMA
PHYSICA PHARMA
Galia Investissements I
France
Exited
Sector
Pharma
InvestorGalia Gestion
Entry
2004
Hold
12yr
Exit
2016
to Unither Pharmaceuticals
AB7 HOLDING
SGCP Evergreen (balance sheet)
France
Exited
Sector
Pharma
InvestorSociete Generale Capital Partenaires
Entry
2007
Hold
9yr
Exit
2016
ADVANCED ACCELERATOR APPLICATIONS
Naxicap Legacy Funds
France
Exited
Sector
Pharma
InvestorNaxicap Partners
Entry
2008
Hold
8yr
Exit
2016
to Novartis AG
ALIZÉ PHARMA II SAS
Capital Santé 2
France
Exited
Sector
Pharma
InvestorTurenne Groupe
Entry
2014
Hold
2yr
Exit
2016
to Jazz Pharmaceuticals
PHARM’UP
PHARM’UP
Naxicap Legacy Funds
France
Exited
Sector
Pharma
InvestorNaxicap Partners
Entry
2010
Hold
5yr
Exit
2015
CAMED
IPDEV 1
France
Exited
Sector
Pharma
InvestorInvestisseurs et Partenaires
Entry
2003
Hold
8yr
Exit
2011
to Local pharmacists and a French pharmaceutical wholesaler supplier
PHARMASTER (LABORATOIRES)
Naxicap Legacy Funds
France
Exited
Sector
Pharma
InvestorNaxicap Partners
Entry
2003
Hold
7yr
Exit
2010
Ipsen
PAI LBO Fund
France
Exited
Sector
Pharma
InvestorPAI Partners
Entry
1998
Hold
8yr
Exit
2006
Medix
EMZ Legacy
France
Exited
Sector
Pharma
InvestorEMZ Partners
Entry
2001
Hold
3yr
Exit
2004
Piex
Piex
LBO France Mid Cap
France
Active
Sector
Pharma
InvestorLBO France
Entry
2017
Hold
9yr
Owners
4
Neftys Pharma
Neftys Pharma
For Talents Transmission
France
Active
Sector
Pharma
InvestorFor Talents Transmission
Entry
2022
Hold
4yr
Owners
3
Biogaran
Biogaran
Bpifrance
France
Active
Sector
Pharma
InvestorBpifrance Investissement
Entry
2025
Hold
1yr
Owners
2
Gen Orph
Gen Orph
Crédit Mutuel Equity
France
Active
Sector
Pharma
InvestorCrédit Mutuel Equity
Entry
2014
Hold
12yr
Owners
2
Naogen Pharma
Naogen Pharma
Altur Investissement
France
Active
Sector
Pharma
InvestorAltur Investissement
Entry
2018
Hold
8yr
Owners
2
AB7
AB7
Grand Sud Ouest Capital
France
Active
Sector
Pharma
InvestorGrand Sud-Ouest Capital
Entry
2010
Hold
16yr
AdipoPharma
AdipoPharma
Cap Innov'Est 1
France
Active
Sector
Pharma
InvestorCapital Grand Est
Entry
–
ADVICENNE
ADVICENNE
IRDInov
France
Active
Sector
Pharma
InvestorIrdi Capital-Investissement
Entry
2017
Hold
9yr
Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies
Cathay Health
France
Active
Sector
Pharma
InvestorCathay Capital
Entry
–
Axience
Axience
Motion Equity Partners Fund
France
Active
Sector
Pharma
InvestorMotion Equity Partners
Entry
2024
Hold
2yr
Bioluz
Bioluz
IDES (Institut de Développement de l’Economie Sociale)
France
Active
Sector
Pharma
InvestorESFIN GESTION
Entry
2013
Hold
13yr
CERES
CERES
NIO II
France
Active
Sector
Pharma
InvestorNaxicap Partners
Entry
2021
Hold
5yr
Ceva Animal Health
Ceva Animal Health
MED Rise
France
Active
Sector
Pharma
InvestorARCHIMED
Entry
2025
Hold
1yr
Galenicum
Galenicum
Peninsula Investments Europe
France
Active
Sector
Pharma
InvestorPeninsula Capital
Entry
2021
Hold
5yr
H.A.C.Pharma
H.A.C.Pharma
Capital Santé 2
France
Active
Sector
Pharma
InvestorTurenne Groupe
Entry
2022
Hold
4yr
Previous12Next